What's Hot

    A failed trial for a coronary heart drug casts shadow over rivals growing comparable therapies | Invesloan.com

    November 9, 2026

    Trump says he doubts Democrats will attempt to impeach him a 3rd time | Invesloan.com

    November 9, 2026

    I Spent 6 Months Traveling All Over the Country to Visit Friends | Invesloan.com

    November 9, 2026
    Facebook Twitter Instagram
    Finance Pro
    Facebook Twitter Instagram
    invesloan.cominvesloan.com
    Subscribe for Alerts
    • Home
    • News
    • Politics
    • Money
    • Personal Finance
    • Business
    • Economy
    • Investing
    • Markets
      • Stocks
      • Futures & Commodities
      • Crypto
      • Forex
    • Technology
    invesloan.cominvesloan.com
    Home » A failed trial for a coronary heart drug casts shadow over rivals growing comparable therapies | Invesloan.com
    News

    A failed trial for a coronary heart drug casts shadow over rivals growing comparable therapies | Invesloan.com

    November 9, 2026
    Share
    Facebook Twitter LinkedIn Pinterest Email


    The full data from the closely watched clinical trial showed that the drug had no cardiovascular benefit even though it reduced Lp(a) levels.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Keep Reading

    JPMorgan turns bearish on Molson Coors amid weak beer traits (TAP:NYSE) | Invesloan.com

    Until AI sentiment improves, Citi tells buyers it’s higher to take a seat out the worldwide tech commerce | Invesloan.com

    Trump says he was kidding about making UFC boss press secretary | Invesloan.com

    How Wall Street is reacting to the information of Nvidia’s investigation into Jensen Huang spy claims | Invesloan.com

    Elon Musk’s Terafab targets 1M wafers per 30 days by 2032 – report (TSLA:NASDAQ) | Invesloan.com

    New England Realty Associates Limited Partnership declares $0.40 dividend | Invesloan.com

    Berkshire plans second yen-denominated bond providing of 2026 (BRK.B:NYSE) | Invesloan.com

    Nvidia down because it opens evaluate into alleged Chinese spy effort focusing on CEO Huang (NVDA:NASDAQ) | Invesloan.com

    Novo Nordisk studies liver enhancements with Wegovy in some sufferers | Invesloan.com

    LATEST NEWS

    A failed trial for a coronary heart drug casts shadow over rivals growing comparable therapies | Invesloan.com

    November 9, 2026

    Trump says he doubts Democrats will attempt to impeach him a 3rd time | Invesloan.com

    November 9, 2026

    I Spent 6 Months Traveling All Over the Country to Visit Friends | Invesloan.com

    November 9, 2026

    JPMorgan turns bearish on Molson Coors amid weak beer traits (TAP:NYSE) | Invesloan.com

    November 9, 2026
    POPULAR

    China’s first passenger jet completes maiden commercial flight

    May 28, 2023

    Numbers taking US accountancy exams drop to lowest level in 17 years

    May 29, 2023

    Toyota chair faces removal vote over governance issues

    May 29, 2023
    Advertisement
    Load WordPress Sites in as fast as 37ms!
    Facebook Twitter Pinterest WhatsApp Instagram
    © 2007-2023 Invesloan.com All Rights Reserved.
    • Privacy
    • Terms
    • Press Release
    • Advertise
    • Contact

    Type above and press Enter to search. Press Esc to cancel.

    invesloan.com
    Manage Cookie Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    • Manage options
    • Manage services
    • Manage {vendor_count} vendors
    • Read more about these purposes
    View preferences
    • {title}
    • {title}
    • {title}